SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001102624-16-002321
Filing Date
2016-03-15
Accepted
2016-03-15 16:26:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 BOSTON THERAPEUTICS, INC. SCHEDULE 13D/A bostontherapapeutics13d.htm SC 13D/A 253858
  Complete submission text file 0001102624-16-002321.txt   255182
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Subject) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87827 | Film No.: 161507228
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1525 VOORHIES AVENUE BROOKLYN NY 11235
Business Address
Parnes Harold S (Filed by) CIK: 0001634060 (see all company filings)

Type: SC 13D/A